Company Filing History:
Years Active: 2012-2025
Title: The Innovative Contributions of Vincent Petit
Introduction
Vincent Petit is a notable inventor based in Paris, France, recognized for his significant contributions to the field of biotechnology. With a total of six patents to his name, Petit has focused on developing methods for diagnosing and treating diseases related to specific transporters in biological systems. His work has implications for both medical diagnostics and therapeutic interventions.
Latest Patents
Among his latest patents, Petit has developed methods utilizing ligands derived from the receptor-binding domain of porcine endogenous retrovirus type B for diagnosing sodium-dependent multivitamin transporter (SMVT)-related diseases. These methods involve contacting a biological sample with a PERV-B.RBD ligand and measuring its binding to SMVT. Additionally, he has patented methods for diagnosing cationic l-amino acid transporter (CAT1)-related diseases using a receptor-binding domain derived from bovine leukemia virus. This includes the use of a BLV.RBD ligand for both diagnosis and treatment of CAT1-related diseases.
Career Highlights
Vincent Petit has worked with several prominent companies in the biotechnology sector, including Metafora Biosystems and Cassidian Test & Services. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects that advance the understanding of transport mechanisms in biological systems.
Collaborations
Throughout his career, Petit has collaborated with esteemed colleagues such as Pierre Lecoq and Marc Sitbon. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies in the field.
Conclusion
Vincent Petit stands out as a significant figure in the realm of biotechnology, with his innovative patents and collaborations paving the way for advancements in medical diagnostics and treatment. His work continues to impact the scientific community and improve health outcomes.